市販クロラムフェニコール錠の人におけるBioavailabilityについての研究
スポンサーリンク
概要
- 論文の詳細を見る
Since there are few reports on the bioavailability of various commercial pharmaceutics sold on Japanese markets in human beings, some experiments were carried out on commercial chloramphenicol tablets (250 mg/tablet). Products from 16 firms were examined for the antibiotic content and disintegration time, and five brands showing different values were selected to measure their serum level in humans. A total of 25 healthy females were selected for each brand and assigned by the Latin square method. Each person was made to take two tablets (500 mg) at a time, and serum level of chloramphenicol was measured 1,2,3,and 6 hr later. Values were also measured after 6,8,10,and 12 hr for three of these brands. Consequently, the serum level was measured in a total of 134 persons. Average values of maximum serum level ratio were 100,89,86,72,and 55% for the five brands, and the average values of area ratio below the serum level curves were 100,92,91,64,and 46%. These differences in the values are considered to be due to the difference in the manufacturing technology, especially in the use of additives.
- 社団法人日本薬学会の論文
- 1975-05-25
著者
関連論文
- エリスロマイシン錠のヒトでのBioavailabilityと副作用との関係
- 腸溶性剤皮の溶解pHのErythromycin腸溶錠のヒトにおけるBioavailabilityに与える影響
- スルファメトキサゾールの製剤加工度のBioavailabilityに及ぼす影響
- 市販エリスロマイシン錠の品質と投与後のヒト血中濃度との関係
- 市販クロラムフェニコール錠の人血中濃度と溶出速度との関係
- 市販クロラムフェニコール錠の人におけるBioavailabilityについての研究
- GOT・GPT異常値を示した結核患者の服薬調査--1976年国立療養所薬剤協同研究班(共同研究班報告)
- The study of Antimode in races of the acetylation genetic diversity.
- タイトル無し
- タイトル無し
- タイトル無し